Spetea Mariana, Greiner Elisabeth, Aceto Mario D, Harris Louis S, Coop Andrew, Schmidhammer Helmut
Department of Pharmaceutical Chemistry, Institute of Pharmacy and Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innrain 52a, A-6020 Innsbruck, Austria.
J Med Chem. 2005 Jul 28;48(15):5052-5. doi: 10.1021/jm0580205.
In a continued effort to find new substitution patterns in morphinans that would produce strong antinociception while inducing lesser side effects, 4,5-oxygen bridge-opened 6-cyano-substituted N-methylmorphinans (1-3) were synthesized. All compounds showed high affinities in the low nanomolar range to the mu opioid receptor and decreased interaction with delta and kappa receptors, thus being mu selective. When tested in vivo, the 6-cyanomorphinanas acted as potent antinociceptive agents which were either more active or equipotent to their 6-keto analogues 4-6.
为了持续努力寻找吗啡喃类化合物中的新取代模式,以产生强效镇痛作用同时减少副作用,合成了4,5-氧桥开环的6-氰基取代的N-甲基吗啡喃类化合物(1-3)。所有化合物在低纳摩尔范围内对μ阿片受体具有高亲和力,并且与δ和κ受体的相互作用减弱,因此具有μ选择性。在体内测试时,6-氰基吗啡喃类化合物作为强效镇痛剂,其活性要么高于其6-酮类似物4-6,要么与它们相当。